Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Free Cash Flow (2021 - 2025)

Rxo's Free Cash Flow history spans 5 years, with the latest figure at -$9.0 million for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 52.63% year-over-year to -$9.0 million; the TTM value through Dec 2025 reached -$8.0 million, up 85.96%, while the annual FY2025 figure was -$8.0 million, 85.96% up from the prior year.
  • Free Cash Flow reached -$9.0 million in Q4 2025 per RXO's latest filing, down from $9.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $91.0 million in Q1 2022 to a low of -$19.0 million in Q4 2024.
  • Average Free Cash Flow over 5 years is $14.1 million, with a median of $8.0 million recorded in 2023.
  • Peak YoY movement for Free Cash Flow: plummeted 2000.0% in 2024, then soared 156.25% in 2025.
  • A 5-year view of Free Cash Flow shows it stood at $27.0 million in 2021, then soared by 114.81% to $58.0 million in 2022, then crashed by 98.28% to $1.0 million in 2023, then tumbled by 2000.0% to -$19.0 million in 2024, then skyrocketed by 52.63% to -$9.0 million in 2025.
  • Per Business Quant, the three most recent readings for RXO's Free Cash Flow are -$9.0 million (Q4 2025), $9.0 million (Q3 2025), and $9.0 million (Q2 2025).